Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial Subanalysis

Salomon Manier; Meletios A Dimopoulos; Cyrille Hulin; Xavier Leleu; Michel Delforge; Katja Weisel; Jorge Mouro; Bruno Costa; Michael Sturniolo; Thierry Façon

doi:10.1016/j.clml.2023.06.002

Related publications

Article2019

Characterization of Relapse and Second-Line Therapy in Lenalidomide-Refractory, Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma: A Subanalysis of the Phase 3 First Trial

Salmon Manier, Meletios A Dimopoulos, Cyrille Hulin, Xavier Leleu, Michel Delforge, Katja Weisel, Ruiyun Jiang, Shankar Srinivasan, Bruno Costa, Suzanne Robinson, Thierry Façon

Article2012

Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma

Antonio Palumbo, Roman Hájek, Michel Delforge, Martin Kropff, Maria Teresa Petrucci, John Catalano, Heinz Gisslinger, W Wiktor-Jędrzejczak, Mamia Zodelava, Katja Weisel, Nicola Cascavilla, Genadi Iosava, Michèle Cavo, Janusz Kłoczko, Joan Bladé, Meral Beksaç, Ivan Špıčka, Torben Plesner, J. Radke, Christian Langer, Dina Ben Yehuda, Alessandro Corso, Lindsay Herbein, Zhinuan Yu, Jay Mei, Christian Jacques, Meletios A Dimopoulos

Article2015

Continuous Lenalidomide and Low-Dose Dexamethasone for the Treatment of Patients with Newly Diagnosed Multiple Myeloma and Renal Impairment in the First Trial

Meletios A Dimopoulos, Matthew C. Cheung, Murielle Roussel, Ting Liu, Barbara Gamberi, Brigitte Kolb, Hans Günter Derigs, Hyeon‐Seok Eom, Karim Belhadj, Pascal Lenain, Richard van der Jagt, Sophie Rigaudeau, R. Hall, Arnaud Jaccard, Axel Tosikyan, Lionel Karlin, Jack W. Singer, Rik Schots, G. Chen, J Marek, Annette Ervin‐Haynes, Thierry Façon

Article2015

Continuous Treatment With Lenalidomide and Low-Dose Dexamethasone for Patients With Transplant-Ineligible Newly Diagnosed Multiple Myeloma in the First Trial: Impact of Age

Cyrille Hulin, Chaim Shustik, Andrew Belch, Maria Teresa Petrucci, Ulrich Dührsen, Jin Lu, Kevin Song, Philippe Rodon, Laurent Garderet, Hannah Hunter, I Azaïs, Richard Eek, Margaret Macro, Shaker R. Dakhil, Vanessa Houck, G. Chen, Annette Ervin‐Haynes, Fritz Offner, Meletios A Dimopoulos, Thierry Façon

Article2021

Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics

Paul G. Richardson, Fredrik Schjesvold, Katja Weisel, Philippe Moreau, Larry D. Anderson, Darrell White, Paula Rodríguez‐Otero, Pieter Sonneveld, Monika Engelhardt, Matthew Jenner, Alessandro Corso, Jan Dürig, Michel Pavic, Morten Salomo, Meral Beksaç, Albert Oriol, Jindriska Lindsay, Anna Marina Liberati, Mónica Galli, Paweł Robak, Alessandra Larocca, Münci Yağcı, Filiz Vural,